Standardization of a direct agglutination test for the immunodiagnosis of Chagas disease

被引:0
作者
Alviarez, Yenny [1 ,2 ]
Lares, Maria [1 ]
Viettri, Mercedes [1 ]
Aguilar, Cruz M. [3 ]
Herrera, Leidi [4 ]
Ferrer, Elizabeth [1 ,5 ]
机构
[1] Univ Carabobo, Inst Invest Biomed Dr Francisco J Triana Alonso, Sede Aragua, Maracay, Venezuela
[2] Univ Carabobo, Fac Ciencias Salud, Dept Clin Integral, Sede Aragua, Maracay, Venezuela
[3] Univ Carabobo, Fac Ciencias Salud, Ctr Invest Enfermedades Trop, San Carlos, Venezuela
[4] Cent Univ Venezuela, Fac Ciencias, Inst Zool & Ecol Trop, Caracas, Venezuela
[5] Univ Carabobo, Fac Ciencias Salud, Dept Parasitol, Maracay, Venezuela
来源
BIOMEDICA | 2014年 / 34卷 / 02期
关键词
Chagas disease; Trypanosoma cruzi; immunologic tests; parasites; antibodies; TRYPANOSOMA-CRUZI INFECTION; SEROLOGICAL DIAGNOSIS; WESTERN VENEZUELA; PATHOGENESIS; LESIONS; AREA; DNA;
D O I
10.7705/biomedica.v34i2.2078
中图分类号
R188.11 [热带医学];
学科分类号
摘要
Introduction: Chagas' disease is caused by the parasite Trypanosoma cruzi and its immunological diagnosis is mainly based on the detection of antibodies against T. cruzi using tests such as the ELISA, the indirect fluorescence antibody test (IFAT) and the indirect hemagglutination test (IHAT). The main disadvantage of the IHAT is the need to prepare sheep erythrocytes, whose availability is limited and they have a short duration once prepared. However, there are alternative tests, such as the direct agglutination test (DAT). Objective: To standardize the direct agglutination test for the diagnosis of Chagas disease. Materials and methods: Trypanosoma cruzi epimastigotes were prepared using two protocols, with and without trypsin treatment. The parasites were stained and optimal conditions for parasitic concentration and serum dilutions were determined. We evaluated the technique using sera from patients with Chagas disease, from healthy individuals and from individuals with other parasitic diseases. Results: The optimal parasitic concentration was 500 x 10(6) parasites/ml using stained parasites without trypsin treatment. The optimal serum dilutions were 1/25, 1/50 y 1/100 and the cut-off point was the 1/50 dilution. The diagnostic indices for the standardized technique were as follows: Sensitivity, 94.3% (95% CI: 79.5-99.0) and specificity, 96.3% (95% CI: 88.8-99.0), with positive and negative predictive values of 91.7% (95% CI: 76.4-97.8) and 97.5% (95% CI: 90.4-99.6), respectively. Cross-reaction was observed only in three sera from individuals with visceral leishmaniasis. The results were compared with those obtained by IHA, ELISA, and IFA, and the concordance rate was 96% and the kappa index, 0.90 (95% CI: 0.81-0.99). Conclusion: The standardized direct agglutination test could be useful for immunodiagnosis of Chagas disease.
引用
收藏
页码:308 / 317
页数:10
相关论文
共 50 条
  • [41] Trypanosoma cruzi persistence in the native heart is associated with high-grade myocarditis, but not with Chagas' disease reactivation after heart transplantation
    Benvenuti, Luiz A.
    Roggerio, Alessandra
    Nishiya, Anna S.
    Campos, Silvia V.
    Fiorelli, Alfredo I.
    Levi, Jose E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (07) : 698 - 703
  • [42] Validation of a direct agglutination test prototype kit for the diagnosis of visceral leishmaniasis
    Oliveira, Edward
    Saliba, Soraya Wilke
    Saliba, Juliana Wilke
    Rabello, Ana
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2013, 107 (04) : 243 - 247
  • [43] Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease
    Castro-Sesquen, Yagahira E.
    Gilman, Robert H.
    Galdos-Cardenas, Gerson
    Ferrufino, Lisbeth
    Sanchez, Gerardo
    Valencia Ayala, Edward
    Liotta, Lance
    Bern, Caryn
    Luchini, Alessandra
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (10):
  • [44] Effectiveness of Nitazoxanide and Electrolyzed Oxiding Water in Treating Chagas Disease in a Canine Model
    Rodriguez-Morales, Olivia
    Jocelin Mendoza-Tellez, Erika
    Morales-Salinas, Elizabeth
    Arce-Fonseca, Minerva
    PHARMACEUTICS, 2023, 15 (05)
  • [45] Nitazoxanide: A Drug Repositioning Compound with Potential Use in Chagas Disease in a Murine Model
    Arce-Fonseca, Minerva
    Gutierrez-Ocejo, Rodolfo Andres
    Rosales-Encina, Jose Luis
    Aranda-Fraustro, Alberto
    Cabrera-Mata, Juan Jose
    Rodriguez-Morales, Olivia
    PHARMACEUTICALS, 2023, 16 (06)
  • [46] An update on benznidazole for the treatment of patients with Chagas disease
    Thakare, R.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2018, 54 (01) : 15 - 23
  • [47] Potential new clinical therapies for Chagas disease
    Bustamante, Juan M.
    Tarleton, Rick L.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (03) : 317 - 325
  • [48] Immunodiagnosis of Chagas disease: Synthesis of three latex-protein complexes containing different antigens of Trypanosoma cruzi
    Gonzalez, Veronica D. G.
    Garcia, Valeria S.
    Vega, Jorge R.
    Marcipar, Ivan S.
    Meira, Gregorio R.
    Gugliotta, Luis M.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 77 (01) : 12 - 17
  • [49] Flavonoids and Chagas' Disease: The Story So Far!
    Nabavi, Seyed Fazel
    Sureda, Antoni
    Daglia, Maria
    Izadi, Morteza
    Rastrelli, Luca
    Nabavi, Seyed Mohammad
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (04) : 460 - 466
  • [50] Chagas disease in prehistoric populations of northern Chile
    Orellana-Halkyer, Nancy
    Arriaza-Torres, Bernardo
    REVISTA CHILENA DE HISTORIA NATURAL, 2010, 83 (04) : 531 - 541